BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 12599433)

  • 21. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Devazepide reversed effect of sincalide against morphine on rat jejunal activities.
    Xu MY; Yang XP; Jin HB; Yang CX; Yang LZ
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):419-22. PubMed ID: 10678088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of gastrin and cholecystokinin fragments on the secretion of triacylglycerol in rat hepatocytes.
    Lindholm M; Eklund A
    Hepatology; 1993 Nov; 18(5):1232-7. PubMed ID: 8225230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney.
    von Schrenck T; Ahrens M; de Weerth A; Bobrowski C; Wolf G; Jonas L; Jocks T; Schulz M; Bläker M; Neumaier M; Stahl RA
    Kidney Int; 2000 Sep; 58(3):995-1003. PubMed ID: 10972664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat.
    Santucci V; Gueudet C; Thurneyssen O; Gully D; Soubrie P; Le Fur G
    Ann N Y Acad Sci; 1994 Mar; 713():364-7. PubMed ID: 8185189
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
    Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
    J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anodal polarization induces protein kinase C gamma (PKC gamma)-like immunoreactivity in the rat cerebral cortex.
    Islam N; Moriwaki A; Hattori Y; Hori Y
    Neurosci Res; 1994 Dec; 21(2):169-72. PubMed ID: 7724068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes.
    Migaud M; Roques BP; Durieux C
    Eur J Neurosci; 1995 May; 7(5):1074-9. PubMed ID: 7613612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1995 Mar; 118(1):57-64. PubMed ID: 7597123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities.
    Ohtsuka T; Kotaki H; Nakayama N; Itezono Y; Shimma N; Kudoh T; Kuwahara T; Arisawa M; Yokose K; Seto H
    J Antibiot (Tokyo); 1993 Jan; 46(1):11-7. PubMed ID: 8436543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PKC translocation in rat brain cortex is promoted in vivo and in vitro by alpha-glycerylphosphorylcholine, a cognition-enhancing drug.
    Govoni S; Battaini F; Lucchi L; Pascale A; Trabucchi M
    Ann N Y Acad Sci; 1993 Sep; 695():307-10. PubMed ID: 8239301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats.
    Lucchi L; Pascale A; Battaini F; Govoni S; Trabucchi M
    Life Sci; 1993; 53(24):1821-32. PubMed ID: 8246681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C increase in rat brain cortical membranes may be promoted by cognition enhancing drugs.
    Govoni S; Lucchi L; Battaini F; Trabucchi M
    Life Sci; 1992; 50(16):PL125-8. PubMed ID: 1552828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase C activity in rat brain cortex.
    Crumrine RC; LaManna JC
    J Neurochem; 1990 Sep; 55(3):826-31. PubMed ID: 2384756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous system.
    Boden PR; Pinnock RD; Pritchard MC; Woodruff GN
    Br J Pharmacol; 1994 Jun; 112(2):666-70. PubMed ID: 8075886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic enhancement of visual learning by activation of protein kinase C pathways in small groups of rat cortical neurons.
    Zhang GR; Wang X; Kong L; Lu XG; Lee B; Liu M; Sun M; Franklin C; Cook RG; Geller AI
    J Neurosci; 2005 Sep; 25(37):8468-81. PubMed ID: 16162929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C activity and intracellular distribution in surgically excised human epileptic neocortex.
    Vernet O; Yong VW; Rostworowski K; Fadich M; Olivier A; Sherwin AL
    Brain Res; 1991 May; 547(2):319-22. PubMed ID: 1884207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of cholecystokinin octapeptide on PKC activity in rat cerebral cortex neurocytes].
    Xiang P; Qiu M; Du Z; Chen M; Wu Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):72-4, 120. PubMed ID: 12599433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCKB receptor stimulation mediates [Ca2+]i increase but no PKC activation in Jurkat T-cells.
    Kaufmann R; Lindschau C; Buchner K; Ott T
    Neuroreport; 1992 Aug; 3(8):697-9. PubMed ID: 1520857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.